Cardiovascular disease prevention and lifestyle interventions: Effectiveness and efficacy

Journal of Cardiovascular Nursing

Volumn 18, Issue 4, 2003, Pages 245-255

  Haskell, William L ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cardiovascular disease; Case management; Lifestyle; Prevention; Risk factors

Indexed keywords

CARDIOVASCULAR DISEASE; DEPRESSION; DIET; EVIDENCE BASED MEDICINE; EXERCISE; GENETIC PREDISPOSITION; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMAN; MENTAL STRESS; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIMARY PREVENTION; REVIEW; RISK FACTOR; RISK REDUCTION; SMOKING; SOCIAL SUPPORT; TREATMENT OUTCOME;

CARDIOVASCULAR DISEASES; DEPRESSION; DIABETES MELLITUS, TYPE 2; DIET; EVIDENCE-BASED MEDICINE; EXERCISE; GENETIC PREDISPOSITION TO DISEASE; HEALTH BEHAVIOR; HEALTH PROMOTION; HUMANS; OBESITY; PRIMARY PREVENTION; RISK FACTORS; RISK REDUCTION BEHAVIOR; SMOKING; SOCIAL SUPPORT; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME;

EID: 0142243203     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200309000-00003     Document Type: Article

References (56)

1. McKeigue PM, Miller GJ, Marmot MG. Coronary heart disease in South Asians overseas: a review. J Clin Epidemiol. 1989;42:597-609.
2. Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases. Part II, Variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation. 2001;104:2855-2864.
3. Leon DA. Fetal growth and adult disease. Eur J Clin Nutr. 1998;52:S72-S82.
4. Berenson GS, Srinivasan SR, Bao W, et al. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults: The Bogalusa Heart Study. N Engl J Med. 1998;338:1650-1656.
5. Diaz MN, Frei B, Vita J, et al. Antioxidants and atherosclerotic heart disease. N Engl J Med. 1997;337:408-416.
6. Fuster V, Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. Circulation. 1995;91:2126-2146.
7. Waters D, Lespérance J, Gladstone P, et al. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. Circulation. 1996;97:614-621.
8. Schoenborn CA, Vickerie JL, Barnes PM. Cigarette smoking behavior of adults: United States, 1997-98. Advanced data. Hyattsville, Md: Department of Health and Human Services; 2003. Number 3311-3327.
9. Parrott S, Godfrey C, Raw M, West R, McNeill A, for the Health Education Authority. Guidance for commissioners on the cost effectiveness of smoking cessation interventions. Thorax. 1998;53(suppl 2):S1-S38.
10. The Tobacco Use and Dependence Clinical Practice Guidelines Panel, Staff and Consortium Representatives. A clinical practice guideline for treating tobacco use and dependence: A US Public Health Service Report. JAMA. 283;3244-3254.
11. Hu FB, Willett WC. Optimal diets for prevention of coronary heart disease. JAMA. 2002;288:2569-2578.
12. Hu FB, Rimm EB, Stampfer J, Ascherio A, Spiegelman D, Willett WC. Prospective study of major dietary patterns and risk of coronary heart disease in men. Am J Clin Nutr. 2000;72:912-921.
13. Albert CM, Gaziano JM, Willett WC, Manson JE. Nut consumption and decreased risk of sudden cardiac death in the physician's health study. Arch Intern Med. 2002;162:1382-1387.
14. He K, Rimm ER, Merchant A, et al. Fish consumption and risk of stroke in men. JAMA. 2002;288:3130-3136.
15. Singh RB, Rastogi SS, Verma R, et al. An Indian experiment with nutritional modulation in acute myocardial infarction. Am J Cardiol. 1992;69:879-885.
16. Logeril DE, Renaud MD, Mamelle N, et al. Mediterrean alpha-linolenic acid-rich diet, in secondary prevention of coronary heart disease. Lancet. 1994;343:1454-14359.
17. Nestle M. Food Politics: How the Food Industry Influences Nutrition and Health. Berkeley, Calif: University of California Press; 2002.
18. Myers J, Prakash M, Froelicher V, Do D, Partington S, Atwood JE. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med. 2002;346:793-801.
19. Tanasescu M, Leitzmann MF, Rimm EB, Willett WC, Stampfer MJ, Hu FB. Exercise type and intensity in relation to coronary heart disease. JAMA. 2002;288:1994-2000.
20. Manson JE, Greenland P, LaCroux A, et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med. 2002;347:716-725.
21. Oldridge NB, Guyatt GH, Fischer ME, Rimm AA. Cardiac rehabilitation after myocardial infarction. JAMA. 1988;260:945-950.
22. Glelen S, Hambrecht R. Effects of exercise training on vascular function and myocardial perfusion. Cardiol Clin. 2001;19:357-368.
23. Todd IC, Ballantyne D. Antianginal efficacy of exercise training: a comparison with beta blocake. Br Heart J. 1990;64:14-19.
24. Fletcher GF, Balady G, Blair Sn, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans. Circulation. 1996;94:857-862.
25. Pate PR, Pratt M, Blair SN, et al. Physical activity and public health: a recommendation from the Centers for Disease Control and Prevention and the American College of Sports Medicine. JAMA. 1995;273:402-407.
26. Mokdad AH, Serdula MK, Dietz WH, Bowman BA, Marks JS, Koplan JP. The spread of the obesity epidemic in the United States. 1991-1998. JAMA. 1999;282:1519-1522.
27. Lee I-M, Blair SN, Allison DB, et al. Epidemiologic data on the relationships of calorie intake. Energy balance, and weight gain over the life span with longevity and mortality. J Gerontol A. 2001;56:7-19.
28. Mokdad AH, Ford ES, Bowman BA, et al. Prevalence of obesity, diabetes, and obesity-related health risk factors, 2002. JAMA. 2003;289:76-79.
29. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497.
30. Xiao-Ren P, Guang-Wei L, Ying-Hua H, et al. Effects of diet and exercise in preventing NIDDK in people with impaired glucose tolerance: The Da Quing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
31. Tuomilehto J, Lindstrom J, Ericksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344:1443-1450.
32. Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or Metformin. N Engl J Med. 2002;346:393-404.
33. Bunker SJ, Colquhoun DM, Ester MD, et al. “Stress” and coronary heart disease: psychological risk factors. Med J Aust. 2003;178:272-276.
34. Sheps DS, McMahon RP, Becker L, et al. Mental-stress induced ischemia and all-cause mortality in patients with coronary heart disease. Circulation. 2002;105:1780-1784.
35. Friedman M, Thoresen CE, Gill JJ, et al. Alteration in type A behavior and its effect on cardiac recurrences in post-myocardial infarction patients: summary results of the Recurrent Coronary Prevention Project. Am Heart J. 1986;12:653-665.
36. Czajkowski SM, Carney R, O'Conner C. The ENRICHED Trial: treating depression and low social support after myocardial infarction in a diverse patient population. Ann Behav Med. 2002;204:xi.
37. Ford DE, Mead LA, Chang PP, Cooper-Patrick L, Wang NY, Klag MJ. Depression as a risk factor for coronary artery disease in men: the precursors study. Arch Intern Med. 1998;158:1422-1426.
38. Frasure-Smith N, Lesperance F, Gravel G, et al. Social support, depression, and mortality during the first year after myocardial infarction. Circulation. 2000;101:1919-1924.
39. Rugulies R. Depression as a risk factor for coronary hearty disease: a review and meta-analysis. Am J Prev Med. 2002;23:51-61.
40. Ziegeistien RC. Depression in patients recovering from a myocardial infarction. JAMA. 2001;286:1621-1627.
41. Gerin W, Pieper C, Levy R, Pickering TG. Social support and social interaction: a moderator of cardiovascular reactivity. Psychosom Med. 1992;54:324-336.
42. Goldbourt U, Yaari S, Medalie JH. Factor predictive of long-term coronary heart disease mortality among 10,059 male Israeli civil servants and municipal employees. A 23-year mortality follow-up in the Israeli ischemic heart disease study. Cardiology. 1993;82:100-121.
43. Oxman TE, Freeman DH, Manheimer ED. Lack of social participation or religious strength and comfort as risk factors for death after cardiac surgery in the elderly. Psychosom Med. 1995;57:5-15.
44. Smith SC, Blair SN, Bonow RO, et al. AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update. Circulation. 2001;104:1577-1579.
45. Fletcher GF, Balady GJ, Vogel RA. 33rd Bethesda Conference. Preventive cardiology: how can we do better? J Am Coll Cardiol. 2002;40:580-651.
46. Ornish D, Brown SE, Scherwitz LW, et al. Can lifestyle changes reverse coronary heart disease? Lancet. 1990;336:129-133.
47. Niebauer J, Hambrecht R, Velich T, et al. Attenuated progression of coronary artery disease after 6 years of multifactorial risk intervention. Circulation. 1997;96:2534-2541.
48. Haskell W, Aldermann AL, Fair JM, et al. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease: The Stanford Coronary Risk Intervention Project (SCRIP). Circulation. 1994;89:975-990.
49. DeBusk RF, Miller NH, Superko HR, et al. A case-management system of coronary risk factor modification after acute myocardial infarction. Ann Intern Med. 1994;120:721-729.
50. Watts GF, Lewis B, Brunt JNH, et al. Effects on coronary artery disease of lipid-lowering diet or diet plus cholestyramine in the St. Thomas Atherosclerosis Regression Study. Lancet. 1992;339:563-569.
51. Gade P, Vedel P, Larsen N, et al. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2003;348:383-393.
52. Sdringola S, Nakagawa K, Nakawaga Y, et al. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary heart disease. J Am Coll Cardiol. 2003;41:263-272.
53. Miller NH, Warren D, Myers D. Home-based cardiac rehabilitation and lifestyle modification: the MULTIFIT model. J Cardiovasc Nurs. 1996;11:76-87.
54. Perrigo ES, Marinett WI, Roberts JC, et al. Regression of carotid arteriosclerosis with life-style changes and risk factor interventions. Circulation. 2002;106(suppl):II-557.
55. Amed A. Quality and outcomes of heart failure care in older adults: role of multidisciplinary disease-management programs. J Am Geriatr Soc. 2002;50:1590-1593.
56. Gordon NF, Haskell WL. Comprehensive cardiovascular disease risk reduction in a cardiac rehabilitation setting. Am J Cardiol. 1997;80:69H-73H.